These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28232871)

  • 1. Serotonin receptors in depression: from A to B.
    Nautiyal KM; Hen R
    F1000Res; 2017; 6():123. PubMed ID: 28232871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HT1B receptor: a novel target for the pathophysiology of depression.
    Ruf BM; Bhagwagar Z
    Curr Drug Targets; 2009 Nov; 10(11):1118-38. PubMed ID: 19702551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.
    Fakhoury M
    Mol Neurobiol; 2016 Jul; 53(5):2778-2786. PubMed ID: 25823514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity.
    Vahid-Ansari F; Zhang M; Zahrai A; Albert PR
    Front Neurosci; 2019; 13():404. PubMed ID: 31114473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.
    Parsey RV; Oquendo MA; Ogden RT; Olvet DM; Simpson N; Huang YY; Van Heertum RL; Arango V; Mann JJ
    Biol Psychiatry; 2006 Jan; 59(2):106-13. PubMed ID: 16154547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors.
    Nautiyal KM; Tritschler L; Ahmari SE; David DJ; Gardier AM; Hen R
    Neuropsychopharmacology; 2016 Nov; 41(12):2941-2950. PubMed ID: 27353308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin receptors involved in antidepressant effects.
    Artigas F
    Pharmacol Ther; 2013 Jan; 137(1):119-31. PubMed ID: 23022360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder.
    Murrough JW; Henry S; Hu J; Gallezot JD; Planeta-Wilson B; Neumaier JF; Neumeister A
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):547-53. PubMed ID: 20480149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
    Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
    Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants.
    Stahl SM; Kaiser L; Roeschen J; Keppel Hesselink JM; Orazem J
    Int J Neuropsychopharmacol; 1998 Jul; 1(1):11-18. PubMed ID: 11281940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study.
    Sato H; Skelin I; Diksic M
    Brain Res; 2010 Jul; 1345():28-44. PubMed ID: 20501324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized placebo-controlled PET study of ketamine´s effect on serotonin
    Tiger M; Veldman ER; Ekman CJ; Halldin C; Svenningsson P; Lundberg J
    Transl Psychiatry; 2020 Jun; 10(1):159. PubMed ID: 32475989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice.
    Bechtholt AJ; Smith K; Gaughan S; Lucki I
    Physiol Behav; 2008 Mar; 93(4-5):659-65. PubMed ID: 18155098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT
    Tiger M; Varnäs K; Okubo Y; Lundberg J
    Psychopharmacology (Berl); 2018 May; 235(5):1317-1334. PubMed ID: 29546551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei.
    Greenwood BN; Foley TE; Day HE; Burhans D; Brooks L; Campeau S; Fleshner M
    Biol Psychiatry; 2005 Mar; 57(5):559-68. PubMed ID: 15737672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors.
    Zhu H; Huang Q; Xu H; Niu L; Zhou JN
    Behav Brain Res; 2009 Jan; 196(2):200-6. PubMed ID: 18817816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.